Fusarin C acts like an estrogenic agonist and stimulates breast cancer cells in vitro

Toxicol Lett. 2011 Aug 28;205(2):116-21. doi: 10.1016/j.toxlet.2011.05.1029. Epub 2011 Jun 13.

Abstract

Fusarin C is a mycotoxin produced by several Fusarium species and has been associated with esophageal cancer due to its carcinogenic effects. Here, we report that fusarin C stimulates growth of the breast cancer cell line MCF-7. This suggests that fusarin C can act as an estrogenic agonist and should be classified as a mycoestrogen. MCF-7 cells were stimulated in the range between 0.1 and 20μM and inhibited when the concentration exceeded 50μM. The toxicity of fusarin C is comparable to other mycoestrogens such as zearalenone, but the chemical structure of fusarin C is very different from other known estrogen agonists. Furthermore, the toxicity of fusarin C was tested in five additional human cell lines Caco 2, U266, PC3, MDA-MB-231 and MCF-10a which were all inhibited when the concentration of fusarin C exceeded 10μM. To the best of our knowledge this is the first report on the mycoestrogenic properties of fusarin C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / chemically induced*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Estrogen Receptor alpha / agonists*
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor beta / agonists*
  • Estrogen Receptor beta / genetics
  • Female
  • Fusarium / metabolism
  • Humans
  • Inhibitory Concentration 50
  • Molecular Structure
  • Polyenes / isolation & purification
  • Polyenes / toxicity*
  • Recombinant Proteins / agonists
  • Recombinant Proteins / genetics

Substances

  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Polyenes
  • Recombinant Proteins
  • fusarin C